11-75983387-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003369.4(UVRAG):āc.700A>Gā(p.Lys234Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000601 in 1,498,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003369.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UVRAG | NM_003369.4 | c.700A>G | p.Lys234Glu | missense_variant, splice_region_variant | 8/15 | ENST00000356136.8 | NP_003360.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UVRAG | ENST00000356136.8 | c.700A>G | p.Lys234Glu | missense_variant, splice_region_variant | 8/15 | 1 | NM_003369.4 | ENSP00000348455.3 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 150034Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000298 AC: 4AN: 134032Hom.: 0 AF XY: 0.0000139 AC XY: 1AN XY: 72176
GnomAD4 exome AF: 0.00000519 AC: 7AN: 1348054Hom.: 0 Cov.: 30 AF XY: 0.00000599 AC XY: 4AN XY: 667718
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150034Hom.: 0 Cov.: 32 AF XY: 0.0000274 AC XY: 2AN XY: 73092
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.700A>G (p.K234E) alteration is located in exon 8 (coding exon 8) of the UVRAG gene. This alteration results from a A to G substitution at nucleotide position 700, causing the lysine (K) at amino acid position 234 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at